Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning
The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with breast, lung, and/or genito-urinary cancers treated at Penn State Cancer Institute and their loved ones perform advance care planning. The main questions it aims to answer are: * What modifications and/or adaptations are necessary to Hello for use in cancer populations? * How do different delivery models compare for recruitment in terms of feasibility and efficiency? Participants will: * Complete pre-game questionnaires * Play the Hello game * Complete post-game questionnaires * Participate in a focus group
Checked against the public recordLast updated Feb 28, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Milton S. Hershey Medical Center
- Interventions being studied
- Other: End-of-life conversation game called "Hello"
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria Cancer Patient: * Adults (\> 18 years old) * Able to speak and read English * Be an individual diagnosed with breast, lung, or genitourinary/prostate cancer as verified by primary oncologist or is the chosen caregiver for a participant with those cancers * Receives care at Penn State Health or is the chosen caregiver for a participant treated at Penn State Health Inclusion Criteria Caregiver/Loved one: * Adults (\> 18 years old) * Able to speak and read English and/or Spanish * Be the chosen caregiver for a participant with cancer Exclusion Criteria Cancer Patient: * Anyone \<18 years of age * Anyone unable to speak and read English * Unable to provide informed consent * Receives cancer care exclusively outside of Penn State Health Exclusion Criteria Caregiver/Loved one: * Anyone \<18 years of age * Anyone unable to speak and read English * Unable to provide informed consent
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Penn State Cancer InstituteHershey, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 28, 2024. Always confirm current availability with the study team.